Recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for non-small cell lung cancer
- 31 December 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (5) , 677-680
- https://doi.org/10.1016/s0959-8049(05)80345-4
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Phase II Study of Cisplatin Continuous Infusion plus Vindesine in the Treatment of Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1992
- Phase II study of 5-day continuous infusion ofcis-diamminedichloroplatinum(II) in the treatment of non-small-cell lung cancerCancer Chemotherapy and Pharmacology, 1990
- Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the UrotheliumNew England Journal of Medicine, 1988
- EFFECT OF GRANULOCYTE COLONY STIMULATING FACTOR ON NEUTROPENIA INDUCED BY CYTOTOXIC CHEMOTHERAPYThe Lancet, 1988
- Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancerBritish Journal of Cancer, 1987
- Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factorNature, 1986